Show Notes
Why do South Asians experience higher rates of heart disease and type 2 diabetes earlier in life? Cardiovascular disease is the leading cause of death in women worldwide, and South Asians carry a disproportionate burden of heart disease and type 2 diabetes, often at younger ages and lower body weights than other groups. In this episode, we sit down with Dr. Alka Kanaya, anInternal Medicine physician and Professor of Medicine at UCSF, founding Principal Investigator of the groundbreaking MASALA Study (Mediators of Atherosclerosis in South Asians Living in America).We discuss what a decade-plus of data is teaching us, with a special spotlight on women.
Show Notes: Association Between Plant-Based Dietary Patterns and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Intern Med. September 30, 2019. Content used under license from the JAMA Network® © American Medical Association 1. Cardiovascular Risk Factor Profiles in North and South Indian and Pakistani Americans: The MASALA Study. American Heart Journal. 2022. Reddy NK, Kaushal V, Kanaya AM, et al.Opinion 2. Diabetes in South Asians: Uncovering Novel Risk Factors With Longitudinal Epidemiologic Data: Kelly West Award Lecture 2023. Diabetes Care. 2024. Kanaya AM.Review 3. Prevalence and Trends in Cardiovascular Risk Factors Among Middle-Aged South Asian Adults Compared With Other Racial and Ethnic Groups in the United States: A Longitudinal Analysis of 2 Cohort Studies. Journal of the American Heart Association. 2026. Pedamallu H, Aghabazaz Z, Lancki N, et al.Recent 4. Parity, Weight Change, and Maternal Risk of Cardiovascular events. American Journal of Obstetrics and Gynecology. 2017. Klingberg S, Brekke HK, Winkvist A, et al. 5. Multiparity Is Associated With Poorer Cardiovascular Health Among Women From the Multi-Ethnic Study of Atherosclerosis. American Journal of Obstetrics and Gynecology. 2019. Ogunmoroti O, Osibogun O, Kolade OB, et al. 6. Beyond the Coronaries: Utility of Extra-Coronary Calcification for Cardiovascular Risk Assessment in Women. Current Atherosclerosis Reports. 2026. Littman E, Bukhari S, Watts H, et al.RecentReview 7. Atherosclerotic Cardiovascular Risk Before and After Type 2 Diabetes Onset and the Roles of Ectopic Fat and Ethnic Variation: The 2025 Edwin Bierman Award Lecture. Diabetes. 2025. Sattar N.RecentReview 8. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation. 2018. Volgman AS, Palaniappan LS, Aggarwal NT, et al.Guideline 9. A Healthy Plant-Based Diet Is Favorably Associated With Cardiometabolic Risk Factors Among Participants of South Asian Ancestry. The American Journal of Clinical Nutrition. 2022. Bhupathiraju SN, Sawicki CM, Goon S, et al. 10. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2023. Kwan TW, Wong SS, Hong Y, et al.Guideline 11. Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018. Brown HL, Warner JJ, Gianos E, et al.Guideline 12. Sex-Specific Differences in Cardiovascular Risk Factors and Implications for Cardiovascular Disease Prevention in Women. Atherosclerosis. 2023. Rajendran A, Minhas AS, Kazzi B, et al.Review 13. Evolving Role of Calcium Density in Coronary Artery Calcium Scoring And Atherosclerotic Cardiovascular Disease Risk. JACC. Cardiovascular Imaging. 2022. Razavi AC, Agatston AS, Shaw LJ, et al.Review
More from Avaaz Health
f you’ve been told your cholesterol is “borderline” and it’s being monitored, or you’re already on cholesterol-lowering medication and are wondering if the goalposts recently moved – they did.
Peptides are being promoted everywhere.For weight loss, injury recovery, muscle growth, skin, hair, sleep, andanti-aging. But what are peptides, which ones are actually evidence-based, andwhich claims should make you pause? In this episode of the Avaaz HealthPodcast, Dr. Madhu and Dr. Nav break down the science behind peptide therapy.Our moderator Rup, guides the conversation as we discuss established peptidemedicines and the difference between regulated prescriptions and experimentalproducts being marketed online, and why popularity on TikTok or in gym cultureis not proof of safety or effectiveness. We also discuss retatrutide, a newerinvestigational medication attracting attention for its early weight-managementresearch, and we dive into the risks of unregulated “recovery,” “anti-aging,”and “glow” peptide stacks. Before considering a peptide, rememberthe three Ps: Is it proven? Is it prescribed? Is itpure? *This Avaaz Health Podcast and thisepisode are for general education only, and is not a substitute for medicaladvice, diagnosis, or treatment. Please speak with a qualified health-careprofessional about your individual circumstances.
Everyone’s heard them. Most people believe at least one. In this episode of the Avaaz Health Podcast, we sit down with Dr. Jiti, oncologist and cancer specialist, to break down some of the most common (and dangerous) health myths circulating right now. From “Why screen if I feel fine?” to “Only smokers get lung cancer,” we unpack what’s fact, what’s fiction, and what you actually need to know to protect your health. We also dive into hormone testing trends, testosterone myths, breast pain fears, mammogram radiation concerns, and the truth about cortisol. 🎧 Listen now and rethink what you thought you knew. #HealthMyths #CancerScreening #PreventiveHealth #WomensHealth #MensHealth #HormoneHealth #Mammogram #LungCancerAwareness #MedicalFacts #AvaazHealth
Everyone’s talking about them—the so-called “magic” weight-loss injections. But what’s actually fact vs. hype? In this episode, we break down GLP-1s (like Ozempic) in a physician-led, evidence-based conversation. How do these medications actually work in the body? Who are they truly for? What are the real benefits beyond weight loss—and what about the side effects and accessibility concerns? From appetite regulation and metabolic health to the risks, costs, and unanswered questions, we’re cutting through the noise to bring you clear, science-backed insights you can trust. Get the skinny on GLP-1s. Listen to the full episode on the Avaaz Health Podcast today. #GLP1 #Ozempic #WeightLossScience #EvidenceBasedMedicine #AvaazHealth
Menopause is everywhere in the conversation right now—but not all the information is accurate. In our latest episode, “Not Your Mother’s Menopause,” we revisit this topic with the latest science-based guidance and break down what women need to know now: ✨ What actually happens during perimenopause?✨ Who should consider Menopause Hormone Therapy (MHT)? And for how long?✨ What exactly is genitourinary syndrome of menopause (GSM) — and why does nobody talk about it?✨ If your libido changes, do you need testosterone? We unpack all of this in a physician-led, evidence-based conversation. 🎧 Listen now wherever you get your podcasts, and watch the episode on Youtube. A huge thank you to the menopause experts whose work informed this episode: • Dr. Ardelle Piper — OBGYN, Menopause Society Certified Practitioner • Dr. Natalie Gamache — Gynecologist & menopause specialist • Dr. Woganee Filate — Respirologist & sleep medicine physician • Dr. Suzanne Rutherford — @thefitphysician